Drug maker Eli Lilly and Co. will invest more than $700 million to beef up its insulin-making capacity in Puerto Rico, France, China and the United States. Diabetes treatments have been the company’s bread-and-butter, but sales have dropped off in recent years due to increasing competition. Diabetes treatments have generated billions in revenues and drug companies are always looking for new medications to profit. An estimated 382 million people worldwide have diabetes, and most require medication to keep their blood sugar levels in check. If not controlled, diabetes can lead to heart disease, kidney disease, dementia, blindness and amputations from ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.